Although serum insulin concentrations significantly increased during the clamping, circulating GPHB5 levels remained unchanged in MetS patients and controls compared with baseline (3.52 ± 1.29 vs. 3.43 ± 1.15 μg/L; Figure 4F). The gene discussed is GPHB5; the disease is metabolic syndrome.